Answers are grounded in this paper and cite their sources.
Background People with Parkinson disease (PD) experience substantial motor, nonmotor, and psychosocial burdens that are often inadequately addressed by pharmacological treatments alone. Mind-body interventions (MBIs), including mindful yoga and expressive arts therapy (EXAT), have shown promise in alleviating stress, increasing quality of life, and improving whole-person health. However, evidence of their comparative effectiveness and underlying mechanisms remains limited, leaving clinicians and patients with little guidance when selecting between these interventions. This study aims to fill this gap. Objective This trial aims to compare the effectiveness of mindful yoga and EXAT in reducing perceived stress, increasing quality of life, and improving whole-person health in people with PD. A secondary aim is to examine potential mechanisms of action, including functional, psychosocial, and gut microbiome–related pathways. Methods We are conducting a 2-arm, parallel-group, active-comparator randomized controlled trial. People with PD are randomly assigned to receive either mindful yoga or EXAT, delivered in six 90-minute sessions every 2 weeks. The primary outcomes are perceived stress and PD-related quality of life. Secondary outcomes include PD-related symptoms and broader quality of life. Potential mediators will cover biopsychosocial domains, including biological and physical factors (gut microbiota, constipation severity and bowel habits, and physical activity) and psychosocial factors (self-compassion, self-efficacy, and perceived social support). Motor assessments are conducted using Mon4t and BooGuu Aspire Fall Risk Management mobile apps. Fecal samples are collected to generate reproducible taxonomic and functional profiles of the gut microbiota. Outcomes are assessed at baseline and 3 months, 9 months, and 12 months after baseline assessment. Comparative effectiveness will be evaluated using linear mixed models, and potential mechanisms, including psychosocial and microbiome features, will be examined through path analysis. We hypothesize that both interventions will reduce stress, increase quality of life, and improve whole-person health, but they will demonstrate different pathways across biopsychosocial domains. Results This study was funded in April 2023, and ethics approval was granted in May 2024. Participant recruitment and data collection began in May 2024 and are ongoing. As of the submission of the manuscript, 144 participants had finished pre- and postintervention assessments (72 in each arm). Final follow-ups are still ongoing. Data analysis has not yet started, and primary findings are expected to be published in December 2026. Conclusions By directly comparing 2 active MBIs and integrating biopsychosocial-spiritual domains, this trial will provide comparative evidence on the effectiveness of MBIs. The findings are intended to guide the selection of mind-body approaches in PD, supporting preference-sensitive, whole-person care and informing integrative models that address the complex needs of this population.
No takes yet. Share an insight, caveat, or question.
Kwok et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: